The metabolic syndrome as a consequence of the obesity pandemic resulted in a
substantial increase in the prevalence of metabolic-associated fatty live disease (MAFLD) …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among
reproductive-age women. Patients with non-alcoholic fatty liver disease (NAFLD) often suffer …

The role of nutrition and diet in the development of non-alcoholic fatty liver disease (NAFLD)
is still not fully understood. In the present study, we determined if dietary pattern and markers …

Introduction and objectives Polycystic ovary syndrome (PCOS) is the most common
endocrinology disorder in women of reproductive age; these patients have a higher risk of …

Background and aims Even as several pharmacological treatments for non‐alcoholic
steatohepatitis (NASH) are in development, the incidence of NASH is increasing on an …

Non-alcoholic fatty liver disease (NAFLD) represents a broad spectrum of liver damage,
ranging from simple steatosis to steatohepatitis and fibrosis; as well, there is a close …

Introduction Considering that both long and short sleep duration may have an association
with nonalcoholic fatty liver disease (NAFLD), in this meta-analysis, we analyzed the dose …

Despite the lack of effective pharmacotherapy against nonalcoholic steatohepatitis (NASH)
and liver fibrosis, vitamin E (vitE) supplementation and lifestyle modifications are …

Non-alcoholic fatty liver disease presents a number of ethical dilemmas. These relate to the
potential harms of diagnosing the disease in health, diagnosing a condition for which there …

Анотація Неалкогольна жирова хвороба печінки (НАЖХП)—поширене захворювання.
Це серйозна проблема для систем охорони здоров'я у світі. Тяжкість захворювання та …